Angiostrongylus cantonensis: Tegumental and hypodermic alterations of the fourth-stage larvae following administration of tribendimidine in vivo and in vitro

Parasitology Research

Volumn 112, Issue 8, 2013, Pages 3035-3040

  Zeng, Xin ^a,b   Wang, Juan ^a,b   Wei, Jie ^a,b   Wu, Feng ^a,b   Fung, Feng ^a,b   Wu, Xiaoying ^b   Sun, Xi ^a,b   Zheng, Huanqing ^a,b   Lv, Zhiyue ^a,b   Wu, Zhongdao ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; TRIBENDIMIDINE; UNCLASSIFIED DRUG;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL JUNCTION; CELL NUCLEUS MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALITIS; IN VITRO STUDY; IN VIVO STUDY; INTEGUMENT; LARVA; MASTOID; MENINGOENCEPHALITIS; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUBCUTANEOUS TISSUE; TRANSMISSION ELECTRON MICROSCOPY;

ANGIOSTRONGYLUS CANTONENSIS;

EID: 84881151465     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-013-3479-z     Document Type: Article

References (25)

1. Abrahams-Sandi E, Hoffmann WH, Graeff-Teixeira C, Schulz-Key H, Geiger SM (2004) Long-term observations on mouse strains experimentally infected with Angiostrongylus costaricensis. Parasitol Res 93(3):230-234
2. Chen HT (1935) Un nouveau nematoda pulmonaire: Pulmonema cantonensis, n.g.n. sp. des rats de Canton. Ann Parasitol Hum Comp 13:312-317
3. Chen KM, Lai SC (2007) Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis. J Antimicrob Chemother 59(2):264-276
4. Courdurier J, Guillon J, Malarde L, Laigret J, Desmoulins G, Schollhammer (1964) Demonstration of the cycle of Angiostrongylus cantonensis in the laboratory: observations on this cycle and anatomo-pathology caused by this parasite in various laboratory animals. Bull Soc Pathol Exot Fil 57(6):1255-1262
5. Hu X, Li JH, Lan L, Wu FF, Zhang EP, Song ZM, Huang HC, Luo FJ, Pan CW, Tan F (2012) In vitro study of the effects of Angiostrongylus cantonensis larvae extracts on apoptosis and dysfunction in the blood-brain barrier (BBB). PLoS One 7(2):e32161
6. Hu Y, Xiao SH, Aroian RV (2009) The new anthelmintic tribendimidine is an l-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist. PLoS Negl Trop Dis 3(8):e499
7. Ishii AI (1987) Pathogenic factors in the later pulmonary phase of Angiostrongylus cantonensis-infected rats. Parasitol Res 73(5):458-465
8. Keiser J, Shu-Hua X, Utzinger J (2006) Effect of tribendimidine on adult Echinostoma caproni harbored in mice, including scanning electron microscopic observations. J Parasitol 92(4):858-862
9. Keiser J, Thiemann K, Endriss Y, Utzinger J (2008a) Strongyloides ratti: in vitro and in vivo activity of tribendimidine. PLoS Negl Trop Dis 2(1):e136
10. Keiser J, Utzinger J, Xiao SH, Odermatt P, Tesana S (2008b) Opisthorchis viverrini: efficacy and tegumental alterations following administration of tribendimidine in vivo and in vitro. Parasitol Res 102(4):771-776
11. Lan KP, Lai SC (2009) Differences of proteolytic enzymes and pathological changes in permissive and nonpermissive animal hosts for Angiostrongylus cantonensis infection. Vet Parasitol 165(3-4):265-272
12. Liu HX, Zhang Y, Lv S, Hu L, Zhou XN (2009) Establishment and observation of the life cycle of Angiostrongylus cantonensis in a laboratory setting. Chin J Pathog Biol 4(11):836-839 (in Chinese)
13. Pearce EJ, Sher A (1987) Mechanisms of immune evasion in schistosomiasis. Contrib Microbiol Immunol 8:219-232
14. Ren HN, Cheng BZ, Zhuang ZN (1987) Experimental therapeutic efficacy of a new anti hookworm drug tribendimidine. Chin J Parasitol Parasit Dis 5(4):262-264 (in Chinese)
15. Wallace GD, Rosen L (1966) Studies on eosinophilic meningitis.2. Experimental infection of shrimp and crabs with Angiostrongylus cantonensis. Am J Epidemiol 84(1):120-131
16. Wang J, Wei J, Zeng X, Liang JY, Wu F, Li ZY, Zheng HQ, He HJ, Wu ZD (2013) Efficacy of tribendimidine against Angiostrongylus cantonensis infection in the mice. Parasitol Res 112(3):1039-1046
17. Wang QP, Wu ZD, Wei J, Owen RL, Lun ZR (2012) Human angiostrongyliasis cantonensis: an update. Eur J Clin Microbiol Infect Dis 31(4):389-395
18. Xiao SH (2004) Tribendimidine - a new anthelmintic. Chin J Parasitol Parasit Dis 22(5):312-315 (in Chinese)
19. Xiao SH, Wu HM, Tanner M, Utzinger J, Wang C (2005) Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 94(1):1-14
20. Xiao SH, Wu ZX, Zhang JH, Wang SQ, Wang SH, Qiu DC, Wang C (2007) Clinical observation on 899 children infected with intestinal nematodes and treated with tribendimidine enteric coated tablets. Chin J Parasitol Parasit Dis 25:372-375 (in Chinese)
21. Xiao SH, Xue J, Tanner M, Zhang YN, Keiser J, Utzinger J, Qiang HQ (2008) Artemether, artesunate, praziquantel and tribendimidine administered singly at different dosages against Clonorchis sinensis: a comparative in vivo study. Acta Trop 106(1):54-59
22. Xiao SH, Xue J, Xu LL, Zheng Q, Qiang HQ, Zhang YN (2009) The in vitro and in vivo effect of tribendimidine and its metabolites against Clonorchis sinensis. Parasitol Res 105(6):1497-1507
23. Yamashita T, Aiba H, Oya H, Fukuda Y (1980) Angiostrongylus cantonensis: development following pulmonary arterial transfers into permissive and nonpermissive hosts. Exp Parasitol 49(3):339-352
24. Yuan G (2010) Metabolism and disposition of tribendimidine and its metabolites in healthy Chinese volunteers. Drugs RD 10(2):83-90
25. Zhang JH, Xiao SH, Wu ZX, Qiu DC, Wang SH, Wang SQ, Wang C (2008) Tribendimidine enteric coated tablet in treatment of 1,292 cases with intestinal nematode infection - a phase IV clinical trial. Chin J Parasitol Parasit Dis 26:6-9 (in Chinese)